The right combination

نویسندگان

چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Transcription factors: The right combination for the DNA lock

Recently determined structures of complexes between homeodomain proteins, their cofactors and DNA have provided new insights into the way pairs of transcription factors can collaborate to select the appropriate target DNA-binding sites during development.

متن کامل

Chlamydia pneumoniae and lipoprotein(a): the right combination for atherosclerosis?

In their provocative report, Glader and collaborators demonstrated the presence of comparable amounts of circulating immunocomplexes with C. pneumoniae antibodies in 78 subjects who later suffered an acute myocardial infarction and in 156 matched controls. No significant difference in the C. pneumonia antibodies (IgG or IgA) titres (soluble or circulating immunocomplex-associated) was detected ...

متن کامل

Choosing the right combination therapy in severe community-acquired pneumonia

Recent studies have suggested that combination antibiotic therapy is preferable to monotherapy for severe community-acquired pneumonia (CAP). In this issue Mortensen and colleagues present retrospective data suggesting that combination therapy with a cephalosporin and a fluoroquinolone is inferior to combination therapy with a cephalosporin and a macrolide. Several mechanisms exist by which qui...

متن کامل

Partner Selection - Finding the Right Combination of Players

In games that model cooperative dilemmas, if players are able to choose with whom they will play, they will seek out cooperative partners while escaping free riders. In this paper we recast the problem of selecting with whom to play as a problem of finding the right combination of players. With this approach, we present a model suitable to any n-player game. The model is adaptive and we present...

متن کامل

Treatment of Multiple Myeloma: Finding the Right Combination.

The treatment of multiple myeloma is evolving rapidly. The development of immunomodulatory drugs (IMiDs) in the late 1990s and proteasome inhibitors (PIs) in the first decade of this century has dramatically changed the outlook for patients, as we began seeing response rates never before imagined. Today the so-called novel agents are no longer novel but standard of care, and are being joined by...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Nature Catalysis

سال: 2019

ISSN: 2520-1158

DOI: 10.1038/s41929-018-0222-2